These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11076495)

  • 1. [Ethical aspects of prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2000 Oct; 141(42):2293-8. PubMed ID: 11076495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ethical aspects of disclosing information on prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2005 Feb; 146(6):259-65. PubMed ID: 15779814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis work-up in prenatal medicine: the example of Down's syndrome].
    Shojai R; Boubli L; d'Ercole C
    Gynecol Obstet Fertil; 2005; 33(7-8):514-9. PubMed ID: 16005658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and legal issues regarding selective abortion of fetuses with Down syndrome.
    Glover NM; Glover SJ
    Ment Retard; 1996 Aug; 34(4):207-14. PubMed ID: 8828339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From a genetic innovation to mass health programmes: the diffusion of Down's Syndrome prenatal screening and diagnostic techniques in France.
    Vassy C
    Soc Sci Med; 2006 Oct; 63(8):2041-51. PubMed ID: 16797810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down's syndrome screening is unethical: views of today's research ethics committees.
    Reynolds TM
    J Clin Pathol; 2003 Apr; 56(4):268-70. PubMed ID: 12663637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods].
    Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification.
    García E; Timmermans DR; van Leeuwen E
    Soc Sci Med; 2008 Feb; 66(3):753-64. PubMed ID: 17996350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations relating to prenatal diagnosis of fetuses with Down syndrome.
    Pueschel SM
    Ment Retard; 1991 Aug; 29(4):185-90. PubMed ID: 1833609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Harris R; Church S; Fiddler M; Rhind J
    Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: retrospective interview study.
    Hall S; Bobrow M; Marteau TM
    BMJ; 2000 Feb; 320(7232):407-12. PubMed ID: 10669444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K; Sandall J
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The attitude of pregnant women to the possibilities for the prenatal screening and diagnosis of Down's syndrome in the 2nd trimester].
    Dimitrova V; Chernev T; Savova S; Stoianova M
    Akush Ginekol (Sofiia); 2000; 39(1):3-9. PubMed ID: 10826326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.